Applications including "Valsartan"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LC Technical Note InertSustain AQ-C18 InertSustain PFP
LB692 - Analysis of Nitrosamines -

LC InertSearch InertSustain AQ-C18
LB691 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LB690 - Analysis of Nitrosamines -

LC InertSearch InertSustain PFP
LT099 - Analysis of Valsartan -

LC Technical Note InertSustain C18
LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustain C18
LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LC InertSearch InertSustainSwift C18
LB386 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-SP) -

LC InertSearch Inertsil ODS-SP
LB385 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB384 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-3) -

LC InertSearch Inertsil ODS-3
LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -

LC InertSearch InertSustainSwift C18
LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -

LC InertSearch InertSustain C18
LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LC InertSearch InertSustain AQ-C18
LB052 - Analysis of Valsartan (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LB022 - Analysis of Losartan potassium and Valsartan -

LC InertSearch InertSustain C18
LB021 - Analysis of Valsartan and Hydrochlorothiazide -

LC InertSearch InertSustain C18
LA967 - Analysis of Valsartan (Inertsil ODS-4) -

LC InertSearch Inertsil ODS-4
LA966 - Analysis of Valsartan (InertSustain C18) -

LC InertSearch InertSustain C18

Applications including "Valsartan"

LT201 - Analysis of nitrosoamines by LC-MS / MS, HPLC using InertSustain AQ-C18 -Comparison with PFP column- -

LB692 - Analysis of Nitrosamines -

LB691 - Analysis of Nitrosamines -

LB690 - Analysis of Nitrosamines -

LT099 - Analysis of Valsartan -

LB520 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB519 - Analysis of Valsartan and Hydrochlorothiazide(Under the Condition of the draft for the Japanese Pharmacopoeia, Valsartan and Hydrochlorothiazide Tablets) -

LB386 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-SP) -

LB385 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-4) -

LB384 - Analysis of Angiotensin II receptor blockers (Inertsil ODS-3) -

LB383 - Analysis of Angiotensin II receptor blockers (InertSustainSwift C18) -

LB382 - Analysis of Angiotensin II receptor blockers (InertSustain C18) -

LB381 - Analysis of Angiotensin II receptor blockers (InertSustain AQ-C18) -

LB052 - Analysis of Valsartan (Inertsil ODS-4) -

LB022 - Analysis of Losartan potassium and Valsartan -

LB021 - Analysis of Valsartan and Hydrochlorothiazide -

LA967 - Analysis of Valsartan (Inertsil ODS-4) -

LA966 - Analysis of Valsartan (InertSustain C18) -

Application Search